$1.4 Billion is the total value of Camber Capital Management LP's 37 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF SPYput | $206,430,000 | +0.4% | 1,000,000 | 0.0% | 14.74% | +7.9% | |
| ESRX | EXPRESS SCRIPTS HLDG CO | $60,739,000 | +2.5% | 700,000 | 0.0% | 4.34% | +10.0% | |
| KERX | KERYX BIOPHARMACEUTICALS INC | $38,190,000 | -10.0% | 3,000,000 | 0.0% | 2.73% | -3.4% | |
| BRKR | BRUKER CORP | $36,940,000 | -5.9% | 2,000,000 | 0.0% | 2.64% | +1.1% | |
| KND | KINDRED HEALTHCARE INC | $35,685,000 | +30.9% | 1,500,000 | 0.0% | 2.55% | +40.5% | |
| AMRN | AMARIN CORP PLCspons adr new | $28,080,000 | +138.9% | 12,000,000 | 0.0% | 2.00% | +156.4% | |
| TRVN | TREVENA INC | $18,712,000 | +9.0% | 2,870,000 | 0.0% | 1.34% | +17.1% | |
| CCRN | CROSS CTRY HEALTHCARE INC | $16,872,000 | -5.0% | 1,422,565 | 0.0% | 1.20% | +2.1% | |
| CRDC | CARDICA INC | $5,274,000 | -10.0% | 8,374,846 | 0.0% | 0.38% | -3.3% | |
| TRGT | TARGACEPT INC | $4,633,000 | +12.9% | 1,560,000 | 0.0% | 0.33% | +21.2% | |
| INO | INOVIO PHARMACEUTICALS INC | $2,040,000 | -11.1% | 250,000 | 0.0% | 0.15% | -4.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.